Study

Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease. – Cost Effective Supplements

Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/12911824


Conclusion of this study

SER may exert a beneficial effect on mucus clearance by reducing neutrophil numbers and altering the viscoelasticity of sputum in patients with chronic airway diseases.


Supplements analyzed in this study

Serrapeptase

Health conditions analyzed in this study

Sinusitis


Moderately Positive
Serrapeptase


Functions related to this study

Immunity


Moderately Positive
Serrapeptase


Body systems related to this study


Respiratory System
Scroll to top